HRES 755119th CongressIntroduced

Expressing support for the goals and ideas of "National Hydrocephalus Awareness Month" and "World Hydrocephalus Day".

Introduced: Sep 19, 2025

Healthcare

Standard Summary

Comprehensive overview in 1-2 paragraphs

This is a non-binding House resolution (H. Res. 755) expressing congressional support for the goals and ideas of National Hydrocephalus Awareness Month and World Hydrocephalus Day. Introduced in the 119th Congress, the measure notes the burden of hydrocephalus—a condition characterized by an abnormal buildup of cerebrospinal fluid in the brain—and cites statistics on prevalence, costs, and treatment challenges. It acknowledges September as National Hydrocephalus Awareness Month and September 20 as World Hydrocephalus Day, and states that Congress should continue to support research to prevent, detect, and treat hydrocephalus. As a resolution, it is a symbolic expression of support and does not authorize new programs or funding.

Key Points

1Defines hydrocephalus and emphasizes its seriousness, noting about 1,000,000 affected in the U.S. and a global incidence of 85 per 100,000; also cites that 1 in 770 babies will develop hydrocephalus.
2Recognizes September as National Hydrocephalus Awareness Month and September 20 as World Hydrocephalus Day, highlighting the role of advocacy groups such as the Hydrocephalus Association and Pediatric Hydrocephalus Foundation.
3Highlights the economic burden, stating national hospital costs related to hydrocephalus exceed $2 billion annually, and notes the high frequency of shunt surgeries (over 36,000 per year) with many emergencies.
4Points out clinical challenges, including that there is no cure, shunt devices have high failure rates, and significant barriers exist for transitioning pediatric patients (ages 18–22) to adult care.
5Signals congressional support for ongoing research to prevent, detect, and treat hydrocephalus, aligning with advocacy organizations’ missions.

Impact Areas

Primary group/area affected: Individuals living with hydrocephalus across all ages and their families, who face treatment burdens, potential complications from shunt surgeries, and the need for ongoing medical care.Secondary group/area affected: Healthcare providers and the healthcare system, including neurosurgeons, pediatric-to-adult care teams, and hospital services that bear substantial treatment costs and manage complex care needs.Additional impacts: Public awareness and education, collaboration with patient advocacy organizations, and potential influence on research priorities. The resolution is symbolic and does not create funding or new regulatory requirements, but it may help shape public dialogue and policy considerations around hydrocephalus research and care.

Generated by gpt-5-nano on Oct 2, 2025